Darden (DRI) Q3 2026 Earnings Call Transcript
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 19 2026
0mins
Should l Buy DRI?
Source: NASDAQ.COM
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DRI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DRI
Wall Street analysts forecast DRI stock price to rise
20 Analyst Rating
13 Buy
7 Hold
0 Sell
Moderate Buy
Current: 192.490
Low
200.00
Averages
224.35
High
261.00
Current: 192.490
Low
200.00
Averages
224.35
High
261.00
About DRI
Darden Restaurants, Inc. is a restaurant company. The Company owns and operates full-service dining restaurants in the United States and Canada under the trade names Olive Garden, LongHorn Steakhouse, Yard House, Ruth's Chris Steak House, Cheddar's Scratch Kitchen, The Capital Grille, Chuy's, Seasons 52, Eddie V's and Bahama Breeze. It owns and operates approximately 2,156 restaurants in the United States and Canada. Its segments include Olive Garden, LongHorn Steakhouse, Fine Dining, and Other Businesses. Olive Garden is a full-service Italian dining restaurant operator in the United States. LongHorn Steakhouse is a full-service steakhouse restaurant, which features a variety of menu items including signature steaks and chicken, as well as salmon, shrimp, ribs, pork chops and burgers. Fine Dining includes Ruth’s Chris, The Capital Grille and Eddie V’s. Other businesses include Cheddar’s Scratch Kitchen, Yard House, Bahama Breeze, Seasons 52, and The Capital Burger.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Olive Garden Introduces New Menu Options to Attract Customers
- Sales Growth: Olive Garden reported a 4.7% increase in total sales during Q3 FY2026, primarily driven by menu changes and enhanced first-party delivery fees, indicating the company's strategic efforts to strengthen its market share in a competitive dining landscape.
- Smaller Portion Menu: The restaurant is rolling out GLP-1-friendly smaller portion options nationwide, priced between $12.99 and $15.99, aimed at attracting calorie-conscious consumers, thereby enhancing customer satisfaction and expanding its customer base.
- Promotion Continuation: Olive Garden plans to extend its “Buy One, Take One” promotion into 2026, starting at $14.99, allowing guests to choose one entree and take home a second, further enriching the dining experience and boosting sales.
- Competitive Market Pressure: Despite a 4.3% year-over-year increase in traffic in February 2026, Olive Garden's performance lags behind other Darden brands, highlighting the intensifying competition in the mid-scale dining sector and necessitating continuous enhancement of its value proposition to maintain market position.
See More
Stock Performance Comparison: EW vs. DRI
- Stock Performance Analysis: EW is currently trading up approximately 0.7%, indicating a relatively stable market performance amidst overall volatility, suggesting cautious optimism from investors regarding its future growth.
- DRI Stock Movement: DRI is up about 1.3% midday Monday, outperforming EW, which may reflect stronger market confidence in DRI or positive impacts from its recent business strategies.
- Market Comparison: The three-month price history chart comparing EW and DRI provides critical decision-making insights for investors, particularly when considering potential investments.
- Investor Sentiment: While both stocks are up, DRI's stronger performance may attract more investor attention, potentially influencing future capital inflows and market dynamics.
See More
Wall Street's Top Dividend Stock Picks
- Diamondback Energy Performance: Diamondback Energy (FANG) recently paid a cash dividend of $1.05 per share, with a dividend yield of about 2%, and analysts expect an average total return of 22% from 2027 to 2030, indicating strong potential in a volatile commodity market.
- Crescent Energy Upgrade: Crescent Energy (CRGY) was upgraded to buy by JPMorgan with a price target of $19, offering a quarterly dividend of 12 cents per share and a yield of 3.5%. Analysts highlighted the company's strong value creation through the acquisition of Vital Energy, despite its high debt levels.
- Darden Restaurants Strong Earnings: Darden Restaurants (DRI) declared a quarterly dividend of $1.50 per share, with an annualized dividend of $6, yielding approximately 3.1%. Despite inflationary pressures, Darden achieved strong same-store sales growth in Q3, leading analysts to maintain an optimistic outlook on its profitability.
- Analyst Ratings Support: Top analysts' buy ratings for FANG, CRGY, and DRI are backed by in-depth macro and micro analyses, showcasing these stocks' attractiveness in the current market environment and helping investors seek stable investment opportunities amid uncertainty.
See More
Trump Pauses Strikes on Iran, Oil Prices Plummet
- Oil Price Volatility: Trump's announcement to pause strikes on Iranian energy infrastructure has led to a 2% rise in U.S. stock futures and over a 9% drop in international oil prices, which could have significant implications for investor confidence in the energy sector.
- Microsoft Crisis Deepens: Analysts suggest that Microsoft's reorganization of Copilot and potential lawsuits against OpenAI and Amazon indicate major challenges for the company, as customer demand shifts towards AI tools, potentially impacting future revenue streams.
- Darden Restaurants Price Target Raised: Bank of America has increased its price target for Darden Restaurants from $262 to $272, reflecting strong market confidence in its brands like Olive Garden, which may attract more investor interest.
- Elliott Management Targets Synopsys: Activist investor Elliott holds a multibillion-dollar stake in Synopsys, aiming to enhance its financial performance, resulting in a more than 4% increase in share price, indicating market recognition of its potential value.
See More
Impact of GLP-1 Drugs on the Restaurant Industry
- Market Threat: According to JPMorgan estimates, the growing adoption of GLP-1 drugs could lead to annual sales losses of $30 billion to $55 billion for the food and beverage industry by 2030, highlighting significant pressure on the restaurant sector.
- Changing Consumption Habits: Surveys indicate that about 60% of GLP-1 users report dining out less frequently, with dinner traffic declining by 6%, which will directly impact restaurant revenues.
- Health Food Opportunities: As GLP-1 drug usage rises, food companies are adjusting their menus to include new protein- and fiber-rich options to attract health-conscious consumers, thereby alleviating sales pressures.
- Market Adaptation Strategies: Restaurant executives state that while the impact of GLP-1 drugs on sales has yet to be fully realized, they are actively innovating their menus to meet consumer demands for lower sugar, higher protein, and fiber-rich foods, ensuring long-term brand competitiveness.
See More
Darden Restaurants Poised for New Heights with Strong Growth and Cash Flow
Stock Performance: Darden Restaurants' stock is expected to reach new highs this year due to strong revenue growth, cash flow generation, and capital returns to investors, as highlighted in their Q3 fiscal year 2026 earnings report.
Financial Outlook: The company reported solid revenue growth and an improved full-year outlook, with analysts predicting higher share prices and a bullish sentiment surrounding the stock.
Challenges and Resilience: Despite facing impairments related to the Bahamas Breeze brand, Darden's other brands, such as Olive Garden and LongHorn Steakhouse, continue to grow, contributing to a revenue increase of 5.9% compared to last year.
Market Sentiment: Analysts remain cautiously optimistic about Darden's future performance, with expectations of continued growth and a strong market position, while also noting potential volatility in stock prices.
See More
Olive Garden Introduces New Menu Options to Attract Customers
- Sales Growth: Olive Garden reported a 4.7% increase in total sales during Q3 FY2026, primarily driven by menu changes and enhanced first-party delivery fees, indicating the company's strategic efforts to strengthen its market share in a competitive dining landscape.
- Smaller Portion Menu: The restaurant is rolling out GLP-1-friendly smaller portion options nationwide, priced between $12.99 and $15.99, aimed at attracting calorie-conscious consumers, thereby enhancing customer satisfaction and expanding its customer base.
- Promotion Continuation: Olive Garden plans to extend its “Buy One, Take One” promotion into 2026, starting at $14.99, allowing guests to choose one entree and take home a second, further enriching the dining experience and boosting sales.
- Competitive Market Pressure: Despite a 4.3% year-over-year increase in traffic in February 2026, Olive Garden's performance lags behind other Darden brands, highlighting the intensifying competition in the mid-scale dining sector and necessitating continuous enhancement of its value proposition to maintain market position.
See More
Stock Performance Comparison: EW vs. DRI
- Stock Performance Analysis: EW is currently trading up approximately 0.7%, indicating a relatively stable market performance amidst overall volatility, suggesting cautious optimism from investors regarding its future growth.
- DRI Stock Movement: DRI is up about 1.3% midday Monday, outperforming EW, which may reflect stronger market confidence in DRI or positive impacts from its recent business strategies.
- Market Comparison: The three-month price history chart comparing EW and DRI provides critical decision-making insights for investors, particularly when considering potential investments.
- Investor Sentiment: While both stocks are up, DRI's stronger performance may attract more investor attention, potentially influencing future capital inflows and market dynamics.
See More
Wall Street's Top Dividend Stock Picks
- Diamondback Energy Performance: Diamondback Energy (FANG) recently paid a cash dividend of $1.05 per share, with a dividend yield of about 2%, and analysts expect an average total return of 22% from 2027 to 2030, indicating strong potential in a volatile commodity market.
- Crescent Energy Upgrade: Crescent Energy (CRGY) was upgraded to buy by JPMorgan with a price target of $19, offering a quarterly dividend of 12 cents per share and a yield of 3.5%. Analysts highlighted the company's strong value creation through the acquisition of Vital Energy, despite its high debt levels.
- Darden Restaurants Strong Earnings: Darden Restaurants (DRI) declared a quarterly dividend of $1.50 per share, with an annualized dividend of $6, yielding approximately 3.1%. Despite inflationary pressures, Darden achieved strong same-store sales growth in Q3, leading analysts to maintain an optimistic outlook on its profitability.
- Analyst Ratings Support: Top analysts' buy ratings for FANG, CRGY, and DRI are backed by in-depth macro and micro analyses, showcasing these stocks' attractiveness in the current market environment and helping investors seek stable investment opportunities amid uncertainty.
See More
Trump Pauses Strikes on Iran, Oil Prices Plummet
- Oil Price Volatility: Trump's announcement to pause strikes on Iranian energy infrastructure has led to a 2% rise in U.S. stock futures and over a 9% drop in international oil prices, which could have significant implications for investor confidence in the energy sector.
- Microsoft Crisis Deepens: Analysts suggest that Microsoft's reorganization of Copilot and potential lawsuits against OpenAI and Amazon indicate major challenges for the company, as customer demand shifts towards AI tools, potentially impacting future revenue streams.
- Darden Restaurants Price Target Raised: Bank of America has increased its price target for Darden Restaurants from $262 to $272, reflecting strong market confidence in its brands like Olive Garden, which may attract more investor interest.
- Elliott Management Targets Synopsys: Activist investor Elliott holds a multibillion-dollar stake in Synopsys, aiming to enhance its financial performance, resulting in a more than 4% increase in share price, indicating market recognition of its potential value.
See More
Impact of GLP-1 Drugs on the Restaurant Industry
- Market Threat: According to JPMorgan estimates, the growing adoption of GLP-1 drugs could lead to annual sales losses of $30 billion to $55 billion for the food and beverage industry by 2030, highlighting significant pressure on the restaurant sector.
- Changing Consumption Habits: Surveys indicate that about 60% of GLP-1 users report dining out less frequently, with dinner traffic declining by 6%, which will directly impact restaurant revenues.
- Health Food Opportunities: As GLP-1 drug usage rises, food companies are adjusting their menus to include new protein- and fiber-rich options to attract health-conscious consumers, thereby alleviating sales pressures.
- Market Adaptation Strategies: Restaurant executives state that while the impact of GLP-1 drugs on sales has yet to be fully realized, they are actively innovating their menus to meet consumer demands for lower sugar, higher protein, and fiber-rich foods, ensuring long-term brand competitiveness.
See More
Darden Restaurants Poised for New Heights with Strong Growth and Cash Flow
Stock Performance: Darden Restaurants' stock is expected to reach new highs this year due to strong revenue growth, cash flow generation, and capital returns to investors, as highlighted in their Q3 fiscal year 2026 earnings report.
Financial Outlook: The company reported solid revenue growth and an improved full-year outlook, with analysts predicting higher share prices and a bullish sentiment surrounding the stock.
Challenges and Resilience: Despite facing impairments related to the Bahamas Breeze brand, Darden's other brands, such as Olive Garden and LongHorn Steakhouse, continue to grow, contributing to a revenue increase of 5.9% compared to last year.
Market Sentiment: Analysts remain cautiously optimistic about Darden's future performance, with expectations of continued growth and a strong market position, while also noting potential volatility in stock prices.
See More
